Tan Patrick Huat-Chye, Hwang William Ying Khee, Goh Yeow Tee, Tan Poh Lin, Koh Liang Piu, Tan Cheng Hoe, Quah Thuan Chong
Department of Hematology, Singapore General Hospital, Singapore.
Am J Hematol. 2004 Apr;75(4):209-12. doi: 10.1002/ajh.20015.
Allogeneic hematopoietic stem cell transplantation is currently the only curative treatment available for thalassemia major. While sibling donors are usually used, unrelated bone marrow transplants have also recently been found to be successful. In this report of two patients, we show that, besides using unrelated bone marrow, peripheral blood stem cell and cord blood transplantations from unrelated donors are viable options. We believe a significant contributory factor in both our cases was the large cell dose used.
异基因造血干细胞移植是目前重型地中海贫血唯一可用的治愈性治疗方法。虽然通常使用同胞供者,但最近也发现无关供者的骨髓移植是成功的。在这份关于两名患者的报告中,我们表明,除了使用无关供者的骨髓外,来自无关供者的外周血干细胞和脐血移植也是可行的选择。我们认为在我们这两个病例中一个重要的促成因素是使用了大剂量的细胞。